The relationship between HLA-B*51 subtypes, clinical manifestations and severity of Behçet's syndrome: a large Italian cohort study

被引:4
作者
Leccese, Pietro [1 ,2 ]
Padula, Maria Carmela [1 ,2 ]
Santospirito, Eustachio Vincenzo [3 ]
Colucci, Rosa [3 ]
Lascaro, Nancy [1 ,2 ]
Padula, Angela Anna [1 ,2 ]
DAngelo, Salvatore [1 ,2 ]
机构
[1] San Carlo Hosp Potenza, Rheumatol Inst Lucania IReL, Via Potito Petrone 1, I-85100 Potenza, Italy
[2] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Via Potito Petrone 1, I-85100 Potenza, Italy
[3] Madonna Grazie Hosp, Tissue Typing Lab, CRT Basilicata, Matera, Italy
关键词
Behcet's syndrome; HLA-B*51; genotyping; subtypes; HLA CLASS-I; BEHCETS-DISEASE; STRONG ASSOCIATION; HLA-B51; SUBTYPES; SILK ROAD; ALLELE;
D O I
10.1093/rap/rkad087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Behcet's syndrome (BS) is a chronic multisystemic inflammatory disorder of unclear aetiology. The predominant BS susceptibility locus was identified within HLA-B*51. HLA-B*51 subtypes were previously studied as disease susceptibility markers. Few data are now available about the relationship between B*51 subtypes and clinical phenotype. The aim of this study was to genotype HLA-B*51 subtypes in a series of Italian BS patients and to test the association with clinical manifestations and disease severity (Krause's index).Methods: HLA-B*51 subtype genotyping for 63 alleles (B*51:01-B*51:63) was performed by PCR after DNA extraction from whole blood of BS patients. The correlation of disease clinical manifestations and severity (Krause's index) with the HLA-B*51 allele and its subtypes was analysed.Results: We enrolled 241 (140 male and 101 female) BS patients, and HLA-B*51 frequency was 62.7% (151 of 241). One hundred and eight of the HLA-B*51-positive patients carried the B*51:01 subtype (108 of 151, 71.5%), 39 of 151 (25.8%) the B*51:08 subtype, 2 of 151 (1.3%) the B*51:02 subtype, 1 of 151 (0.7%) the B*51:05 subtype, and 1 of 151 (0.7%) the B*51:07 subtype. We found that ocular involvement was statistically associated with HLA-B*51 positivity and with B*51:01 and B*51:08 subtypes (P < 0.05). We also found that disease severity was higher in HLA-B*51-positive patients than in negative patients, but without statistical significance (median Krause's index 5.1 vs 4.1, P > 0.05).Conclusion: Here, we confirm a high frequency of the HLA-B*51 allele in our group of BS patients. B*51:01 and B*51:08 were found to be the most common subtypes, and an association of both subtypes with ocular involvement was also underlined.
引用
收藏
页数:6
相关论文
共 15 条
  • [1] HLA-B*51 subtypes molecular analysis in a series of Italian patients with Behvet's syndrome
    Leccese, Pietro
    Padula, Maria Carmela
    Santospirito, Eustachio Vincenzo
    Colucci, Rosa
    Lascaro, Nancy
    D'Angelo, Salvatore
    JOINT BONE SPINE, 2019, 86 (06) : 807 - 808
  • [2] HLA-B51 subtypes in Turkish patients with Behcet's disease and their correlation with clinical manifestations
    Demirseren, D. D.
    Ceylan, G. G.
    Akoglu, G.
    Emre, S.
    Erten, S.
    Arman, A.
    Metin, A.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 4788 - 4796
  • [3] Behçet's Disease: A Comprehensive Review on the Role of HLA-B*51, Antigen Presentation, and Inflammatory Cascade
    Khoshbakht, Saba
    Baskurt, Defne
    Vural, Atay
    Vural, Secil
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [4] Effect of HLA-B*27 and its Subtypes on Clinical Manifestations and Severity of Ankylosing Spondylitis in Iranian Patients
    Fallahi, Sasan
    Mahmoudi, Mahdi
    Nicknam, Mohammad Hossein
    Gharibdoost, Farhad
    Farhadi, Elham
    Saei, Azad
    Nourijelyani, Keramat
    Ahmadzadeh, Noushin
    Jamshidi, Ahmad Reza
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2013, 12 (04) : 321 - 330
  • [5] HLA-B gene methylation and expression in Behçet's syndrome: a potential role of epigenetics in the pathogenesis
    Onen, M. Ozkilinc
    Everest, E.
    Demirci, T.
    Sen, P. Koprulu
    Kisakesen, E. Kiziltepe
    Ozguler, Y.
    Esatoglu, S. N.
    Seyahi, E.
    Turanli, E. Tahir
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (10) : 2014 - 2020
  • [6] Clinical heterogeneity and five phenotypes identified in pediatric Behçet's syndrome: a cohort study from Shanghai Behçet's syndrome database
    Hu, Dan
    She, Chun-Hui
    Bao, Hua-Fang
    Zou, Jun
    Cai, Jian-Fei
    Ye, Jing-Fen
    Shen, Yan
    Ma, Hai Fen
    Luo, Dan
    Guan, Jian-Long
    WORLD JOURNAL OF PEDIATRICS, 2024, 20 (08) : 801 - 808
  • [7] Deficiency of Adenosine Deaminase 2 Masquerading as Behçet's Disease: Phenotypic Mimicry with HLA-B*51 Positivity
    Almojali, Abdullah
    Alrasheed, Abdulrahman
    Alharbi, Bushra
    Alharbi, Reem
    Alsuwairi, Wafaa
    Alroqi, Fayhan
    Alqanatish, Jubran
    JOURNAL OF CLINICAL IMMUNOLOGY, 2025, 45 (01)
  • [8] Genetic testing of Behçet's disease using next-generation sequencing to identify monogenic mimics and HLA-B*51
    Burleigh, Alice
    Omoyinmi, Ebun
    Papadopoulou, Charalampia
    Al-Abadi, Eslam
    Hong, Ying
    Price-Kuehne, Fiona
    Moraitis, Elena
    Titheradge, Hannah
    Montesi, Francesca
    Xu, Diane
    Eleftheriou, Despina
    Brogan, Paul
    RHEUMATOLOGY, 2023, : 3457 - 3470
  • [9] Differences in clinical manifestations, treatment, and concordance rates with two major sets of criteria for Beh‡et's syndrome for patients in the US and Japan: data from a large, three-center cohort study
    Kobayashi, Tatsuo
    Kishimoto, Mitsumasa
    Swearingen, Christopher J.
    Filopoulos, Maria T.
    Ohara, Yuri
    Tokuda, Yasuharu
    Oshikawa, Hideto
    Yoshida, Kazuki
    Utsunomiya, Masako
    Kimura, Makiko
    Okada, Masato
    Matsui, Kazuo
    Yazici, Yusuf
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 547 - 553
  • [10] Evaluation of HLA-B51 frequency and its relationship with clinical findings in patients with Behçet’s disease: 4-year analysis in a single center
    Tuba Erdem Sultanoğlu
    Recep Eröz
    Safinaz Ataoğlu
    Egyptian Rheumatology and Rehabilitation, 50